The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
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
hYX1WDfCjPCeSppR
